Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
J Vet Diagn Invest ; 33(4): 792-796, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33884946

ABSTRACT

An 8-y-old spayed female Beagle dog was presented with peripheral lymphadenomegaly. Lymph node cytology and flow cytometry led to the diagnosis of large B-cell lymphoma (LBCL). We detected minimal percentages of LBCL cells in peripheral blood and bone marrow samples. However, a monomorphic population of neoplastic cells different from those found in the lymph node was found in the bone marrow. T-cell acute lymphoblastic leukemia was suspected based on flow cytometric immunophenotyping. PCR for antigen receptor rearrangement (PARR) revealed clonal rearrangement of both B-cell and T-cell receptors, and the presence of both neoplastic clones in the lymph node, peripheral blood, and bone marrow. The dog was treated with multi-agent chemotherapy but died 46 d following diagnosis. Tumor staging and patient classification are needed to accurately establish a prognosis and select the most appropriate therapeutic protocol.


Subject(s)
Dog Diseases/diagnosis , Leukemia, T-Cell/veterinary , Lymphoma, Large B-Cell, Diffuse/veterinary , Neoplasm Staging/veterinary , Precursor Cell Lymphoblastic Leukemia-Lymphoma/veterinary , Animals , Antineoplastic Agents/administration & dosage , Dog Diseases/pathology , Dogs , Fatal Outcome , Female , Flow Cytometry/veterinary , Immunophenotyping/veterinary , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Prognosis
2.
J Zoo Wildl Med ; 46(3): 580-2, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26352964

ABSTRACT

A 17-yr-old female fallow deer presented with ataxia, inappetence, decreased fecal output, and decreased mentation. A complete blood count demonstrated leukocytosis (24.1×10(3)/µl, n=1.16-7.38×10(3)/µl), characterized by lymphocytosis (22.89×10(3)/µl, n=0.18-3.65×10(3)/µl), anemia (packed cell volume 20%, n=29.0-55.8%), decreased red blood cell count (4.1×10(3)/µl, n=6.86-14.72×10(3)/µl), and decreased hemoglobin (7.5 g/dl, n=9.4-19.2 g/dl). Numerous mature, well-differentiated lymphocytes were noted on the blood film. Despite treatment and clinical improvement, the decision was made to euthanize the deer. Histopathology identified a monomorphic population of CD3 positive, CD79a negative small lymphocytes replacing most of the hematopoietic tissue in the bone marrow without evidence of tissue invasion. Results of viral screening were negative.


Subject(s)
Deer , Leukemia, T-Cell/veterinary , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Dexamethasone/analogs & derivatives , Dexamethasone/therapeutic use , Female , Fluid Therapy , Lactulose/therapeutic use , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/drug therapy , Penicillin G Procaine/therapeutic use
3.
J Avian Med Surg ; 29(4): 326-35, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26771322

ABSTRACT

An asymptomatic 14-year old, male black swan ( Cygnus atratus ) housed at a zoological institution was presented for routine preshipment examination. Hematologic findings indicated that the bird had a severe lymphocytic leukocytosis, consistent with chronic lymphocytic leukemia. Radiographs showed the presence of multiple soft tissue masses within the caudal coelomic cavity; ultrasound showed one mass to be an enlarged spleen, a cystic mass near the gonads, and a mass suspected to be associated with the ventriculus. Results of further antemortem diagnostics, including bone marrow aspiration, fine-needle aspirate cytology of the coelomic masses, and immunohistochemical staining confirmed T-cell leukemia with infiltration of the bone marrow and the spleen. The bird showed partial response to treatment with chlorambucil, lomustine, prednisone, l-asparaginase, and whole-body radiation, with neither evidence of adverse effects nor clinical signs of disease. Although the leukemia showed response, there was no evidence of remission at any point. The swan died 433 days after initial evaluation and initiation of therapy. Necropsy, histopathologic findings, and immunohistochemistry results confirmed extensive infiltration of multiple organs, including the liver, spleen, heart, lungs, and kidneys with neoplastic T-cell lymphocytes.


Subject(s)
Anseriformes , Antineoplastic Agents/therapeutic use , Bird Diseases/diagnosis , Leukemia, T-Cell/veterinary , Animals , Animals, Zoo , Bird Diseases/drug therapy , Leukemia, T-Cell/drug therapy , Male
4.
BMC Vet Res ; 10: 290, 2014 Dec 06.
Article in English | MEDLINE | ID: mdl-25480665

ABSTRACT

BACKGROUND: The antimetabolite 6-thioguanine (6-TG) has been used to treat both human and canine lymphoid malignancies. 6-TG has been shown to be epigenetically active as a demethylating agent in a human lymphoma cell line, causing downregulation of DNA methyltransferase 1 (DNMT1) through ubiquitin-targeted degradation. Zebularine (Zeb), a similar cytidine analog, also has demethylating activity as well as oral bioavailability. The hypothesis of the present study was that 6-TG and Zeb would cause downregulation of DNMT1 and globally demethylate the genomic DNA of canine lymphoma cells. The secondary hypothesis was that these agents would cause a dose-dependent decrease in cell proliferation in canine lymphoma cells. Canine CLGL-90 malignant T cells and CLL 17-7 cells were incubated in modified RPMI media. They were treated with 6-TG, Zeb, or control media at biologically relevant concentrations. RESULTS: Following treatment with each agent, DNMT1 protein and global DNA methylation were significantly decreased. A dose-dependent decrease in cell survival was also observed, with apoptosis being the primary mode of cell death in the CLGL-90 cell line. CONCLUSIONS: These results confirm the demethylating action of 6-TG and Zeb in canine cells which is similar to that shown in human cell lines. Confirmation of this mechanism supports the clinical application of these compounds as demethylating drugs in veterinary patients.


Subject(s)
Antineoplastic Agents/pharmacology , Cytidine/analogs & derivatives , DNA-Cytosine Methylases/antagonists & inhibitors , Dog Diseases/drug therapy , Lymphoma/veterinary , Thioguanine/pharmacology , Animals , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Blotting, Western , Cell Line, Tumor , Cell Proliferation/drug effects , Cytidine/pharmacology , Cytidine/therapeutic use , Dogs , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Leukemia, B-Cell/drug therapy , Leukemia, B-Cell/veterinary , Leukemia, T-Cell/drug therapy , Leukemia, T-Cell/veterinary , Lymphoma/drug therapy , Thioguanine/therapeutic use
5.
J Vet Diagn Invest ; 26(4): 571-574, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24760134

ABSTRACT

Blood smears from a 24-year-old male rhesus macaque ( Macaca mulatta) used for cognitive function studies were evaluated. The macaque had an 8-month history of gradual weight loss and increasing lymphocytosis. Most of the lymphocytes present were small to medium and had a mature morphology. Based on the degree and duration of the lymphocytosis, and the appearance of the lymphocytes, a diagnosis of chronic lymphocytic leukemia was made. The animal tested negative for 4 viral diseases that are commonly associated with lymphoproliferative disorders in Old World monkeys. Over the course of 12 months, the lymphocytosis progressed from 18.4 to 384 × 103 lymphocytes/µl (reference range: 0.8-17 × 103 cells/µl), and euthanasia was elected. On histologic examination, cluster of differentiation (CD)3- and CD8-positive, CD79-negative neoplastic cells comprised 40-60% of the bone marrow, diffusely obscured the normal splenic architecture, and were present in the vascular channels in other organs. Findings were characteristic of T-cell lymphocytic leukemia. Naturally occurring T-cell lymphocytic leukemia has been rarely reported in rhesus macaques and, to the authors' knowledge, never in males. A persistent lymphocytosis characterized by a monomorphic population of CD3- and CD8-positive cytotoxic T-lymphocytes and the presence of neoplastic cells in the bone marrow led to a diagnosis in the current case.


Subject(s)
Leukemia, T-Cell/veterinary , Macaca mulatta , Monkey Diseases/diagnosis , Animals , Leukemia, T-Cell/blood , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/etiology , Lymphocytes/pathology , Male , Monkey Diseases/blood , Monkey Diseases/etiology
6.
Retrovirology ; 10: 118, 2013 Oct 24.
Article in English | MEDLINE | ID: mdl-24156738

ABSTRACT

BACKGROUND: Human T-cell leukemia virus type 1 (HTLV-1) causes chronic infection leading to development of adult T-cell leukemia (ATL) and inflammatory diseases. Non-human primates infected with simian T-cell leukemia virus type 1 (STLV-1) are considered to constitute a suitable animal model for HTLV-1 research. However, the function of the regulatory and accessory genes of STLV-1 has not been analyzed in detail. In this study, STLV-1 in naturally infected Japanese macaques was analyzed. RESULTS: We identified spliced transcripts of STLV-1 corresponding to HTLV-1 tax and HTLV-1 bZIP factor (HBZ). STLV-1 Tax activated the NFAT, AP-1 and NF-κB signaling pathways, whereas STLV-1 bZIP factor (SBZ) suppressed them. Conversely, SBZ enhanced TGF-ß signaling and induced Foxp3 expression. Furthermore, STLV-1 Tax activated the canonical Wnt pathway while SBZ suppressed it. STLV-1 Tax enhanced the viral promoter activity while SBZ suppressed its activation. Then we addressed the clonal proliferation of STLV-1⁺ cells by massively sequencing the provirus integration sites. Some clones proliferated distinctively in monkeys with higher STLV-1 proviral loads. Notably, one of the monkeys surveyed in this study developed T-cell lymphoma in the brain; STLV-1 provirus was integrated in the lymphoma cell genome. When anti-CCR4 antibody, mogamulizumab, was administered into STLV-1-infected monkeys, the proviral load decreased dramatically within 2 weeks. We observed that some abundant clones recovered after discontinuation of mogamulizumab administration. CONCLUSIONS: STLV-1 Tax and SBZ have functions similar to those of their counterparts in HTLV-1. This study demonstrates that Japanese macaques naturally infected with STLV-1 resemble HTLV-1 carriers and are a suitable model for the investigation of persistent HTLV-1 infection and asymptomatic HTLV-1 carrier state. Using these animals, we verified that mogamulizumab, which is currently used as a drug for relapsed ATL, is also effective in reducing the proviral load in asymptomatic individuals.


Subject(s)
Deltaretrovirus Infections/veterinary , Disease Models, Animal , Leukemia, T-Cell/veterinary , Primate Diseases/pathology , Primate Diseases/virology , Primate T-lymphotropic virus 1/isolation & purification , Tumor Virus Infections/veterinary , Animals , Deltaretrovirus Infections/pathology , Deltaretrovirus Infections/virology , Humans , Leukemia, T-Cell/pathology , Leukemia, T-Cell/virology , Macaca , Primate T-lymphotropic virus 1/growth & development , Primate T-lymphotropic virus 1/pathogenicity , Tumor Virus Infections/pathology , Tumor Virus Infections/virology
7.
J Vet Med Sci ; 74(5): 677-80, 2012 May.
Article in English | MEDLINE | ID: mdl-22200671

ABSTRACT

Second malignancies are frequent complications in human patients with chronic lymphocytic leukemia (CLL). However, the clinical details and outcome of this phenomenon were unclear in their canine counterparts. Here, we report a dog with high-grade lymphoma concurrent with T-cell CLL. A 10-year-old male golden retriever presented with lymphadenopathies. The lymph nodes contained large-sized lymphocytes, raising suspicion of high-grade lymphoma. Meanwhile, small lymphocytic lymphocytosis in the peripheral blood was consistent with CLL. Interestingly, molecular biological analyses revealed that CLL cells were of the T-cell type, whereas lymphoma cells were of the B-cell type. Chemotherapy using the L-VCA short protocol was effective for 155 days, but the dog died on day 194 after diagnosis, despite rescue therapies.


Subject(s)
Dog Diseases/pathology , Leukemia, T-Cell/veterinary , Lymphoma, B-Cell/veterinary , Animals , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Dog Diseases/etiology , Dogs , Fatal Outcome , Leukemia, T-Cell/complications , Leukemia, T-Cell/drug therapy , Leukemia, T-Cell/pathology , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/pathology , Male
8.
J Avian Med Surg ; 25(4): 286-94, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22458185

ABSTRACT

An adult, male double yellow-headed Amazon parrot (Amazona ochrocephala oratrix) was diagnosed with chronic lymphocytic leukemia based on results of a complete blood cell count and cytologic examination of a bone marrow aspirate. Treatment with oral chlorambucil was attempted, but no response was evident after 40 days. The bird was euthanatized, and the diagnosis of chronic lymphocytic leukemia was confirmed on gross and microscopic examination of tissues. Neoplastic lymphocytes were found in the bone marrow, liver, kidney, testes, and blood vessels. Based on CD3-positive immunocytochemical and immunohistochemical immunophenotyping, the chronic lymphocytic leukemia was determined to be of T-cell origin.


Subject(s)
Amazona , Leukemia, T-Cell/veterinary , Animals , Antineoplastic Agents, Alkylating/therapeutic use , Chlorambucil/therapeutic use , Chronic Disease , Leukemia, T-Cell/drug therapy , Leukemia, T-Cell/pathology , Male
9.
Vet Clin Pathol ; 37(4): 429-33, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19055579

ABSTRACT

A 4-year-old male, castrated, mixed-breed dog was presented to the Colorado State University Veterinary Teaching Hospital with a 1-week history of polyuria, polydipsia, lethargy, fever, inappetence, weight loss, and soft mucoid stool. The dog was depressed and had pale, icteric mucous membranes. Results of a CBC included normocytic, normochromic, nonregenerative anemia, neutropenia, and thrombocytopenia, with 43% blast cells (200/microL), many of which contained fine azurophilic granules. Cytologic evaluation of the bone marrow aspirates revealed mild granulocytic hyperplasia that appeared to be left-shifted in an apparent maturation arrest. A large population of blast cells comprised 35% of nucleated cells; the blasts had high nuclear to cytoplasmic ratios, deeply basophilic cytoplasm with vacuoles, and prominent nucleoli. Most cells also contained many fine azurophilic granules clustered in the paranuclear region. At necropsy, neoplastic cells were abundant in the bone marrow. Immunohistochemically the cells expressed CD3epsilon, and an oligoclonal T-cell rearrangement was found. The diagnosis was proliferative disorder of CD3(+) granular lymphocytes, with associated pancytopenia. Because the blast cells were morphologically similar to myeloblasts and immunohistochemistry was required to confirm the diagnosis, T-cell lymphoproliferative disease should be considered in dogs with pancytopenia presenting with similar clinical features.


Subject(s)
Dog Diseases/pathology , Leukemia, T-Cell/veterinary , Pancytopenia/veterinary , Animals , Dog Diseases/diagnosis , Dogs , Leukemia, T-Cell/complications , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/pathology , Male , Pancytopenia/complications , Pancytopenia/diagnosis , Pancytopenia/pathology
10.
Equine Vet J ; 39(6): 522-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18065310

ABSTRACT

REASON FOR PERFORMING STUDY: Lymphoid leukaemia (LL) is rare in equids. In man, immunophenotypic classification identifies distinct leukaemic types with different treatment strategies. Improved understanding and classification of equine LL may allow similar advances. OBJECTIVES: To document the clinical, immunophenotypic and functional characteristics in 6 cases of equine LL of T-cell origin. METHODS: The clinical records and pathological findings from 6 cases of equine LL were analysed. Immunohistochemistry to identify T or B lymphocytes was performed on paraffin embedded tissues in 4 cases. Peripheral blood mononuclear cells (PBMC) were phenotyped for expression of CD4, CD8, MHC class I and II and B-cell antigens in 4 cases using monoclonal antibodies (mAbs) and flow cytometry. Neoplastic lymphocytes from 4 horses were stimulated with mitogens. RESULTS AND CONCLUSIONS: Six horses of various breeds were identified with LL of T-cell origin. The clinical course and presenting signs varied. Neoplastic lymphocytes were identified in peripheral blood samples from all horses and tissue invasion was confirmed at examination post mortem in 4 horses. Immunophenotyping identified a predominance of CD3+ T-cells in lymphoid tissues and CD4+ T-cells in circulating peripheral blood mononuclear cells (PBMC) in the affected horses. Neoplastic lymphocytes from the 4 cases that were tested failed to proliferate in response to mitogens. POTENTIAL RELEVANCE: Characterisation of the clinical, pathological and immunological findings in 6 horses with LL has added to reports of this rare condition, characterised it in greater detail and therefore provides a starting point for further investigations.


Subject(s)
CD4 Antigens/metabolism , CD8 Antigens/metabolism , Horse Diseases/pathology , Leukemia, T-Cell/veterinary , Leukocytes, Mononuclear/pathology , Animals , Antibodies, Monoclonal , Bone Marrow Cells/pathology , CD4 Antigens/immunology , CD8 Antigens/immunology , Female , Flow Cytometry/veterinary , Horse Diseases/immunology , Horses , Immunohistochemistry/veterinary , Leukemia, T-Cell/immunology , Leukemia, T-Cell/pathology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Phenotype
11.
J Zoo Wildl Med ; 38(3): 488-91, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17939362

ABSTRACT

Physical examination of an asymptomatic 20-yr-old intact female spotted hyena (Crocuta crocuta) revealed a midabdominal mass. A complete blood count (CBC) revealed peripheral lymphocytosis. Abdominal ultrasonography and laparoscopy confirmed severe splenomegaly. Cytologic examination of a bone-marrow core and histologic examination of spleen and liver biopsy samples revealed neoplastic small lymphocytes. Immunohistochemical staining of liver and spleen samples with the use of leukocyte-specific monoclonal antibodies showed that the neoplastic lymphocytes were immunoreactive to T-lymphocyte CD3 receptor and immunonegative to B-lymphocyte CD79a receptor. The morphology and distribution of neoplastic T-lymphocytes within the spleen, liver, peripheral blood, and bone marrow was most consistent with chronic T-lymphocytic leukemia. Treatment with chlorambucil and prednisone effectively decreased the lymphocyte count, but was associated with thrombocytopenia, which resolved after chlorambucil treatment was temporarily discontinued. Chemotherapy was resumed with a single dose of L-asparaginase, followed by a lower dosage of chlorambucil and continued prednisone. Two years after initial diagnosis, the hyena developed a hemoabdomen and was euthanized. Neoplastic T-lymphocytes were present in spleen, liver, visceral and peripheral lymph nodes, lungs, heart, kidney, adrenal glands, mesentery, intestines, pancreas, brain, and bone marrow.


Subject(s)
Antineoplastic Agents/therapeutic use , Hyaenidae , Leukemia, T-Cell/veterinary , Animals , Antineoplastic Agents/adverse effects , Fatal Outcome , Female , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/drug therapy , Leukemia, T-Cell/pathology , Neoplasm Metastasis , Treatment Outcome
12.
J Vet Med Sci ; 69(6): 677-81, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17611371

ABSTRACT

An 8-year-old spayed female Golden Retriever was referred to us for evaluation of mild lymphocytosis. The peripheral lymphocytes were comprised of mostly large granular lymphocytes (LGLs), and flow cytometry showed that they were mostly CD3+8+ T lymphocytes. Clonal rearrangement of the T-cell receptor gene was identified in the peripheral blood, and the dog was therefore diagnosed with LGL chronic leukemia. The dog was subclinical without treatment until hospitalization on day 154, at which point the lymphocytes looked like lymphoblasts and the surface markers changed to CD3-8-. This was regarded as malignant transformation from LGL chronic leukemia to the acute type. Sequential chemotherapy was started, but the dog died on day 190. Necropsy revealed tumor cell infiltration into the heart, skin, and brain.


Subject(s)
Dog Diseases/pathology , Leukemia, T-Cell/veterinary , Animals , Antineoplastic Agents/therapeutic use , Dogs , Female , Leukemia, T-Cell/drug therapy , Leukemia, T-Cell/pathology , Time Factors
13.
Res Vet Sci ; 79(3): 197-201, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15893350

ABSTRACT

The Bcl-2 gene is the first member of a rapidly expanding family of genes that regulate apoptosis. Bcl-2 has been shown to repress cell death triggered by a diverse array of stimuli including chemotherapy and gamma-irradiation. Chemotherapy of feline lymphoma is generally carried out with antineoplastic drugs, which are reported to induce apoptosis in tumor cells. However, the precise apoptotic signals, induced by chemotherapeutic drugs against feline tumors have not been fully characterized. Therefore, we have evaluated the expression of Bcl-2 and Bcl-xL in FT-1 upon in vitro treatment with these drugs. In the present study, full length of feline Bcl-xL gene was sequenced, and the expressions of Bcl-2 and Bcl-xL mRNAs in feline lymphoma cell line (FT-1) cultured with doxorubicin, prednisolone or vincristine were investigated. Feline Bcl-xL clone was 1163 base pairs in length and encoded 233 amino acids. The predicted amino acid sequence was 99.1%, 98.7%, 96.1%, 97.4%, 97.0% and 97.9% homologous to predicted Bcl-xL of dog, human, mouse, pig, rat and sheep, respectively. The levels of Bcl-2 transcripts at 24h incubation in FT-1 stimulated with doxorubicin (0.3mug/ml), prednisolone (0.2mug/ml) and vincristine (5ng/ml) were increased to about 41.0-, 62.0- and 11.1-fold to those in non-stimulated FT-1, respectively. On the other hand, the level of Bcl-xL transcripts at 24h incubation in FT-1 stimulated by doxorubicin and prednisolone were significantly increased about 4.2- and 5.8-folds to the controls and inducible level of Bcl-xL by vincristine was decreased about 0.35-folds.


Subject(s)
Antineoplastic Agents/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Leukemia, T-Cell/genetics , Leukemia, T-Cell/veterinary , Proto-Oncogene Proteins c-bcl-2/genetics , bcl-X Protein/genetics , Amino Acid Sequence , Animals , Apoptosis/drug effects , Cats , Cell Line, Tumor , Doxorubicin/pharmacology , Leukemia, T-Cell/drug therapy , Molecular Sequence Data , Prednisolone/pharmacology , Sequence Homology, Amino Acid , Vincristine/pharmacology
14.
J Vet Diagn Invest ; 15(4): 330-7, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12918813

ABSTRACT

The aim of this study is to determine the clinical, morphological, and immunophenotypical presentation of 9 cases of a particular type of canine T-cell lymphoma/leukemia. The morphological presentation was a diffuse infiltration of small, medium-sized, or large blast cells with eccentric nuclei, hyperbasophilic cytoplasm, and a juxtanuclear, pale cytoplasmic area, giving a plasmacytoid appearance and suggesting a B-cell morphology. Surprisingly, all 9 cases were of T-cell phenotype (CD3+). Among the 7 immunophenotyped cases, 4 were CD4-/CD8+, 2 CD8+/CD4+, and 1 CD4+/CD8-. The median Ki-67 index was 65.7%, which placed this lymphoma in the high-grade group. This type of lymphoma/leukemia was found in dogs between 1 and 11 years of age, with a median age of 5.8. The male-female ratio was 0.8 for a reference population of 1.04. The most significant clinical findings were lymphadenopathy either generalized or localized in all cases, a mediastinal mass in 4 cases, bone marrow involvement in 7 cases, hypercalcemia in 4 cases, along with an aggressive clinical course and a poor response to chemotherapy in all cases, with a median disease-free survival time of 3 months.


Subject(s)
Dog Diseases/pathology , Leukemia, T-Cell/veterinary , Lymphoma, T-Cell/veterinary , Animals , Disease-Free Survival , Dogs , Female , Immunophenotyping/veterinary , Leukemia, T-Cell/pathology , Lymphoma, T-Cell/pathology , Male , Prognosis , Sex Ratio
15.
J Am Vet Med Assoc ; 217(3): 384-7, 341, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10935045

ABSTRACT

A CD8+ T-cell leukemia was diagnosed in an aged female rhesus macaque. Although leukemia and lymphoma in nonhuman primates are commonly associated with simian T-lymphotropic virus, gibbon ape leukemia virus, oncogenic herpesviruses, and types C, D, and E retroviruses, this monkey was not infected with any of these viruses. However, the monkey did have antibodies against herpesvirus saimiri. This likely represents cross-reactivity of the herpesvirus saimiri assay with rhesus monkey rhadinovirus (RRV) antibodies; RRV was first described in rhesus macaques that were identified as having antibodies against herpesvirus saimiri. Rhesus rhadinovirus is a gamma herpesvirus, related antigenically to herpesvirus saimiri and Kaposi's sarcoma-associated herpesvirus (KSHV), which have been linked to lymphoproliferative disorders in primates and humans, respectively. Moreover, an oncogene has been recently identified in the RRV genome that is equivalent in position to the herpesvirus saimiri and KSHV oncogenes. Presently, the association of RRV infection with disease in nonhuman primates is unknown.


Subject(s)
Leukemia, T-Cell/veterinary , Lymphoproliferative Disorders/veterinary , Macaca mulatta , Monkey Diseases/diagnosis , Age Factors , Animals , Antibodies, Viral/blood , Cross Reactions , Diagnosis, Differential , Female , Herpesvirus 2, Saimiriine/immunology , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/virology , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/virology , Monkey Diseases/virology , Rhadinovirus/immunology
16.
Vet Pathol ; 37(4): 310-7, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10896392

ABSTRACT

We describe a case of large granular lymphocyte (LGL) leukemia in a dog that we followed over a period of 2 years. Analysis of a hematological profile revealed lymphocytosis (19,500 lymphocytes per microliter; reference values, 1,000-4,800 lymphocytes per microliter), with a majority of LGL on the blood smear. LGL is defined as a lymphoid subset comprising 10% of peripheral blood mononuclear cells and corresponding to either CD3- CD8- NK cells or CD3+ CD8+ T cells. The cells are characterized by abundant basophilic cytoplasm containing distinct granules of variable size and number. The characteristic phenotype of our leukemic LGL is of a cytotoxic T cell, CD3+ and CD8+. A new cell line, DLC 02, was established from the peripheral lymphocytes of the leukemic dog. Particles with type C retroviral morphology were found in ultrathin sections of DLC 02 cell pellets. These particles were found to have a sucrose gradient density of 1.17 g/liter and a reverse transcriptase activity with an Mn2+ preference, suggesting that they correspond to a mammalian type C oncovirus.


Subject(s)
Dog Diseases/virology , Gammaretrovirus/isolation & purification , Leukemia, T-Cell/veterinary , Virion/isolation & purification , Animals , Cell Separation/veterinary , Dogs , Female , Flow Cytometry/veterinary , Leukemia, T-Cell/virology , Lymphocyte Count/veterinary , Microscopy, Electron/veterinary , Phenotype , Tumor Cells, Cultured
17.
Can Vet J ; 40(10): 725-8, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10572670

ABSTRACT

A mixed breed dog was diagnosed with large granular lymphocytic leukemia. Immunophenotypic analysis indicated the lymphocytes were CD3+, CD8+ T cells expressing the alpha beta T cell receptor and a leukointegrin, alpha d. Chemotherapy and splenectomy resulted in an initial reduction in the lymphocyte count.


Subject(s)
Dog Diseases/pathology , Leukemia, T-Cell/veterinary , Animals , Antineoplastic Agents/therapeutic use , Dog Diseases/therapy , Dogs , Female , Leukemia, T-Cell/pathology , Leukemia, T-Cell/therapy , Splenectomy/veterinary
18.
Vet Immunol Immunopathol ; 69(2-4): 113-9, 1999 Aug 02.
Article in English | MEDLINE | ID: mdl-10507298

ABSTRACT

We have recently cloned a number of canine T cell receptor (TCR) Vbeta genes using degenerate oligonucleotides. From the DNA sequences of the resulting clones and the canine Vbeta gene sequences in the literature, seven distinct canine TCR Vbeta genes were identified. Vbeta specific PCR primers were designed for each of the seven TCR Vbeta genes such that under defined conditions, each primer could only amplify a specific TCR Vbeta gene in conjunction with the same 3' constant region (Cbeta) primer. By performing RT-PCR on RNA derived from a source containing T lymphocytes, the presence and expansion of T cells expressing a particular Vbeta gene could be detected. Moreover, the clonality or diversity of a T cell population under analysis could be easily determined by the VDJ junctional sequence of the amplified Vbeta PCR product, in the form of a "DNA fingerprint". These findings have been used to detect canine T cell lymphoma, and could potentially be used to monitor the remission of T cell malignancies in response to treatment.


Subject(s)
Dog Diseases/diagnosis , Dog Diseases/genetics , Gene Rearrangement, T-Lymphocyte , Leukemia, T-Cell/veterinary , Receptors, Antigen, T-Cell, alpha-beta/genetics , Animals , DNA Fingerprinting/veterinary , Dogs , Genetic Markers , Leukemia, T-Cell/diagnosis , Leukemia, T-Cell/genetics , Polymerase Chain Reaction/veterinary
19.
AIDS Res Hum Retroviruses ; 14(4): 367-71, 1998 Mar 01.
Article in English | MEDLINE | ID: mdl-9519898

ABSTRACT

Spontaneous T cell leukemia was found in an African green monkey (Cercopithecus aethiops, AGM) naturally infected with simian T cell leukemia virus type I (STLV-I). The hematological features and the evidence for monoclonal integration of provirus DNA in the leukemic cells revealed that the leukemia was an ATL-like disease. The expression of surface markers on the leukemic cells indicated that they were defined as an activated CD8+ T cell subset. Together with the finding that seven in vitro spontaneously STLV-I-transformed cell lines were CD4-CD8+, it is likely that CD8+ T cells are transformed by STLV-I in AGMs, in contrast with human ATL. Finally, we assessed characteristics of the CD8 chains on these transformed cells. The result indicated that the leukemic cells expressed only the alpha chains but not the beta chains. However, in the case of in vitro-transformed cell lines the expression pattern of the CD8 chains varied in individual monkeys. Thus, STLV-I may preferentially transform CD8+ (both alphaalpha+ and alphabeta+) T cells in AGMs.


Subject(s)
CD8-Positive T-Lymphocytes/virology , Chlorocebus aethiops , Deltaretrovirus Infections/veterinary , Deltaretrovirus Infections/virology , Leukemia, T-Cell/veterinary , Leukemia, T-Cell/virology , Monkey Diseases/virology , Simian T-lymphotropic virus 1/pathogenicity , Adult , Animals , CD8-Positive T-Lymphocytes/immunology , Cell Transformation, Viral , Deltaretrovirus Infections/immunology , Female , Humans , Leukemia, T-Cell/immunology , Monkey Diseases/immunology , Receptors, Antigen, T-Cell, alpha-beta/metabolism , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/virology
20.
Scand J Immunol ; 41(3): 298-304, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7871391

ABSTRACT

Induction of anti-tumour immunity in syngeneic mice by LBC cell line derived from a non-immunogenic T cell leukaemia was studied. The immunization of BALB/c mice with LBC irradiated cells induced in them anti-tumour spleen cells, cytotoxic T lymphocytes and anti-LBC antibodies. The anti-LBC antibodies reacted with components of 14, 16 and 27 kDa present on LB tumour cells, LBC cell line and normal thymocytes, but not with normal lymph node cells. Furthermore, immunization of the autologous hosts with LBC cells partially protected them against subsequent challenge with the original LB leukaemic cells. These findings demonstrate that culture conditions induced modifications in the antigenic properties of the leukaemic cells, allowing LBC cells to stimulate an immune response directed against components expressed at early stages during T cell maturation. These results also suggest that the immune response is responsible for the prolongation of the survival time of the mice inoculated with the parental leukaemic cells.


Subject(s)
Neoplasm Transplantation/immunology , Tumor Cells, Cultured/immunology , Animals , Antibodies, Neoplasm/biosynthesis , Cytotoxicity, Immunologic , Female , Immunization , Leukemia, T-Cell/immunology , Leukemia, T-Cell/veterinary , Lymphocyte Activation/immunology , Male , Mice , Mice, Inbred BALB C , Rodent Diseases/immunology , Spleen/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...